Frost-Pineda K et al. |
Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study. |
2011 |
Nicotine Tob. Res. |
pmid:21330277
|
Spectre G et al. |
Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications. |
2011 |
Thromb. Haemost. |
pmid:21800009
|
Hoh CM et al. |
Evaluation of effects of low-dose aspirin administration on urinary thromboxane metabolites in healthy dogs. |
2011 |
Am. J. Vet. Res. |
pmid:21801060
|
Gao F et al. |
Effect of polymorphism and type II diabetes on aspirin resistance in patients with unstable coronary artery disease. |
2011 |
Chin. Med. J. |
pmid:21740787
|
Shen L et al. |
In vivo oxidation, platelet activation and simultaneous occurrence of natural immunity in atherosclerosis-prone mice. |
2011 |
Isr. Med. Assoc. J. |
pmid:21845968
|
Hall JA et al. |
Dietary fish oil alters the lysophospholipid metabolomic profile and decreases urinary 11-dehydro thromboxane Bâ‚‚ concentration in healthy Beagles. |
2011 |
Vet. Immunol. Immunopathol. |
pmid:21925741
|
Lessiani G et al. |
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. |
2011 |
Thromb. Haemost. |
pmid:21103664
|
Lynch CM et al. |
The role of thromboxane A(2) in the pathogenesis of intrauterine growth restriction associated with maternal smoking in pregnancy. |
2011 |
Prostaglandins Other Lipid Mediat. |
pmid:21723954
|
Gonçalves LH et al. |
Urinary 11-dehydro thromboxane Bâ‚‚ levels in type 2 diabetic patients before and during aspirin intake. |
2011 |
Clin. Chim. Acta |
pmid:21510926
|
Gremmel T et al. |
Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation. |
2011 |
Platelets |
pmid:21231857
|